Ehave, Inc. Expands Its KetaDASH Brand And Begins Producing Revenue With The Purchase Of California Based Rejuv IV
February 09, 2022 08:30 ET
|
Ehave
MIAMI, Feb. 09, 2022 (GLOBE NEWSWIRE) -- Ehave, Inc. (OTC Pink: EHVVF) (the “Company”), a leading healthcare services and technology company, reaffirms its commitment to shareholders to launch its...
Ehave Issues Shareholder Letter and Provides Corporate Update
January 31, 2022 08:30 ET
|
Ehave
MIAMI, Jan. 31, 2022 (GLOBE NEWSWIRE) -- Ehave, Inc., (OTC Pink: EHVVF) (the “Company”), a provider of digital therapeutics for the psychedelic and mental health sectors, today issued a letter to...
Ehave Plans Stock Distribution; Mycotopia Therapies Plans To Merge With Ei. Ventures
December 08, 2021 08:00 ET
|
Ehave
Mycotopia and Ei.Ventures announced the signing of an LOI to explore a merger and the formation of PSLY.COM, a $360 Million transaction, and will apply to list shares on NASDAQ; Ehave plans to spin...
2021 Psychedelic Investor Guide Released
October 20, 2021 08:30 ET
|
Ehave
MIAMI, Oct. 20, 2021 (GLOBE NEWSWIRE) -- Ehave, Inc., (OTC Pink: EHVVF) (the “Company”), a provider of digital therapeutics for the psychedelic and mental health sectors, announced today its wholly...
Ehave Hires Contract Research Organization To Conduct Ketamine Clinical Trial In Miami, Florida
October 12, 2021 08:30 ET
|
Ehave
MIAMI, Oct. 12, 2021 (GLOBE NEWSWIRE) -- Ehave, Inc. (OTC Pink: EHVVF) (the “Company”), a provider of digital therapeutics for the psychedelic and mental health sectors, announced today it has...
Psychedelic Stock Review Initiates Coverage on Ehave Inc.
September 30, 2021 08:30 ET
|
Ehave
MIAMI, Sept. 30, 2021 (GLOBE NEWSWIRE) -- Ehave, Inc. (OTC Pink: EHVVF) (the “Company”), a provider of digital therapeutics delivering evidence-based therapeutic interventions to patients, announced...
Ehave Announces Inclusion in the 2021 Psychedelic Investor Guide
September 27, 2021 08:30 ET
|
Ehave
MIAMI, Sept. 27, 2021 (GLOBE NEWSWIRE) -- Ehave, Inc., (OTC Pink: EHVVF) (the “Company”), a provider of digital therapeutics for the psychedelic and mental health sectors, announced today that it...
Ehave Appoints Board-Certified Gastroenterologist And Licensed Physician Dr. Rahul Dixit To Its Medical Advisory Board
September 21, 2021 08:30 ET
|
Ehave
MIAMI, Sept. 21, 2021 (GLOBE NEWSWIRE) -- Ehave, Inc., (OTC Pink: EHVVF) (the “Company”), a provider of digital therapeutics for the psychedelic and mental health sectors, announced today Dr. Rahul...
Ehave Announces Update On Ehave Medical App With The Launch Of Covid Vaccine Passport Going Live Shortly
September 07, 2021 09:49 ET
|
Ehave
MIAMI, Sept. 07, 2021 (GLOBE NEWSWIRE) -- Ehave, Inc. (OTC Pink: EHVVF) (the “Company”), a provider of digital therapeutics delivering evidence-based therapeutic interventions to patients, announced...
Ehave Files 6-K Disclosing LOI Details For The Acquisition Of Moksha Digital Software
August 25, 2021 09:43 ET
|
Ehave
MIAMI, Aug. 25, 2021 (GLOBE NEWSWIRE) -- Ehave, Inc., (OTC Pink: EHVVF) (the “Company”), a provider of digital therapeutics delivering evidence-based therapeutic interventions to patients, announced...